Lifeboat Foundation

Quoted: “Legendary cyberculture icon (and iconoclast) R.U. Sirius and Jay Cornell have written a delicious funcyclopedia of the Singularity, transhumanism, and radical futurism, just published on January 1.” And: “The book, “Transcendence – The Disinformation Encyclopedia of Transhumanism and the Singularity,” is a collection of alphabetically-ordered short chapters about artificial intelligence, cognitive science, genomics, information technology, nanotechnology, neuroscience, space exploration, synthetic biology, robotics, and virtual worlds. Entries range from Cloning and Cyborg Feminism to Designer Babies and Memory-Editing Drugs.” And: “If you are young and don’t remember the 1980s you should know that, before Wired magazine, the cyberculture magazine Mondo 2000 edited by R.U. Sirius covered dangerous hacking, new media and cyberpunk topics such as virtual reality and smart drugs, with an anarchic and subversive slant. As it often happens the more sedate Wired, a watered-down later version of Mondo 2000, was much more successful and went mainstream.”

Read the article here >https://hacked.com/irreverent-singularity-funcyclopedia-mondo-2000s-r-u-sirius/

Corporate Reconnoitering?

ABSOLUTE END.

Authored By Copyright Mr. Andres Agostini

White Swan Book Author (Source of this Article)

http://www.LINKEDIN.com/in/andresagostini

Continue reading “Corporate Reconnoitering?” »

Technologies based on stem cells, genetic engineering or tissue engineering may eventually have considerable impact in alleviating certain diseases such as arthritis, heart disease, or dementia. But these rejuvenation biotechnologies cannot be used by the general public at large in order to negate the ageing process itself.

1. Problems with Stem Cell Therapies

One methodology for delivering biotechnology rejuvenation therapies (such as stem cell therapy) is bone marrow transplant. This is a complex, clinically risky, and administratively complicated procedure. It is well beyond the technical issue of artificially manipulating and repairing cells in the laboratory. Cells need to be harvested from a patient, manipulated in the laboratory, and then re-transplanted in the patient.

Consider what happens during an autologous cell harvest. The patient has to attend a clinic and this may involve a pre-procedure physical assessment, followed by administration of a Colony-Stimulating Factor which is given as an injection every day for up to 14 days, (the patient must be instructed on how to do this at home). A course of chemotherapy may be needed in order to regulate the production of stem cells. The patient returns for another visit for the harvest. The harvesting process takes three to four hours and it may have to be repeated every day for up to five days in order to collect enough cells for the transplant. It involves an epidural or a general anaesthetic (with all the associated risks), punctures over the pelvic bone and withdrawal of marrow material. Alternatively, intravenous access and blood withdrawal need to be arranged. The amount to be withdrawn must be assessed from person to person. The patient needs to recover from the anaesthetic.

Continue reading “A fanciful approach to curing ageing: biotechnology in clinical practice” »

Since ancient times people have been searching for the secret of immortality. Their quest has always been, without exception, about a physical item: a fountain, an elixir, an Alchemist’s remedy, a chalice, a pill, an injection of stem cells or a vial containing gene-repairing material. It has never been about an abstract concept.

Our inability to find a physical cure for ageing is explained by a simple fact: We cannot find it because it does not exist. It will never exist.

Those who believe that someday some guy is going to discover a pill or a remedy and give it to people so that we will all live forever are, regrettably, deluded.

I should highlight here that I refer to a cure for the ageing process in general, and not a cure for a specific medical disease. Biotechnology and other physical therapies are useful in alleviating many diseases and ailments, but these therapies will not be the answer to the basic biological process of ageing.

Continue reading “Alchemy vs Networks: The cure for ageing will come — but it will not be something physical” »

Western Canada’s most futurist-oriented longevity organization, the Lifespan Society of British Columbia, has organized a first-class life extension conference, which will take place later this fall in the heart of downtown Vancouver. The Longevity and Genetics Conference 2014 offers a full-day of expert presentations, made accessible to a general audience, with keynote on the latest developments in biorejuvination by Aubrey de Grey of SENS Research Foundation. The conference will be interactive, with a panel session for audience questions, and VIP options for further interaction with speakers.

Aubrey de Grey

Who will be there? In addition to Aubrey de Grey, there are four other speakers confirmed thus far: Dr. Angela Brooks-Wilson, Head of Cancer Genetics at the Michael Smith Genome Sciences Centre at the BC Cancer Agency, Dr. S. Jay Olshansky, Board of Directors of the American Federation of Aging Research, and co-author of The Quest for Immortality: Science at the Frontiers of Aging, Dr. Clinton Mielke, former Mayo Clinic researcher and founder of the quantified self platform “infino.me”, and lastly, one of futurism’s most experienced and dedicated radical longevity advocates, Benjamin Best, who is currently Director of Research Oversight at the Life Extension Foundation. This conference is a multi-disciplinary event, engaging several points of interest and relevance in the longevity space, from the cellular, genetic science of aging, to the latest epidemiological and even demographic research. You can also expect discussion on personalized medicine and quantified self technologies, as well as big picture, sociological and philosophical, longevity-specific topics.

All around, the 2014 Longevity and Genetics conference, set to take place Saturday November 15, has a lot to offer, as does the host city of Vancouver. A recent study has indicated that a majority of Canadians, 59%, are in favor of life extension technology, with 47% expecting that science and technology will enable living until 120 by 2050. The Lifespan Society of British Columbia is keeping that momentum and enthusiasm alive and growing, and I’m glad they have organized such a high-calliber event. Tickets are currently still available. Learn more about the event and purchase tickets here.

Vancouver B.C.

Would you have your brain preserved? Do you believe your brain is the essence of you?

To noted American PhD Neuroscientist and Futurist, Ken Hayworth, the answer is an emphatic, “Yes.” He is currently developing machines and techniques to map brain tissue at the nanometer scale — the key to encoding our individual identities.

A self-described transhumanist and President of the Brain Preservation Foundation, Hayworth’s goal is to perfect existing preservation techniques, like cryonics, as well as explore and push evolving opportunities to effect a change on the status quo. Currently there is no brain preservation option that offers systematic, scientific evidence as to how much human brain tissue is actually preserved when undergoing today’s experimental preservation methods. Such methods include vitrification, the procedure used in cryonics to try and prevent human organs from freezing and being destroyed when tissue is cooled for cryopreservation.

Hayworth believes we can achieve his vision of preserving an entire human brain at an accepted and proven standard within the next decade. If Hayworth is right, is there a countdown to immortality?

Continue reading “What if your memories could live past your mortal shelf life?” »

What follows is my position piece for London’s FutureFest 2013, the website for which no longer exists.

Medicine is a very ancient practice. In fact, it is so ancient that it may have become obsolete. Medicine aims to restore the mind and body to their natural state relative to an individual’s stage in the life cycle. The idea has been to live as well as possible but also die well when the time came. The sense of what is ‘natural’ was tied to statistically normal ways of living in particular cultures. Past conceptions of health dictated future medical practice. In this respect, medical practitioners may have been wise but they certainly were not progressive.

However, this began to change in the mid-19th century when the great medical experimenter, Claude Bernard, began to champion the idea that medicine should be about the indefinite delaying, if not outright overcoming, of death. Bernard saw organisms as perpetual motion machines in an endless struggle to bring order to an environment that always threatens to consume them. That ‘order’ consists in sustaining the conditions needed to maintain an organism’s indefinite existence. Toward this end, Bernard enthusiastically used animals as living laboratories for testing his various hypotheses.

Historians identify Bernard’s sensibility with the advent of ‘modern medicine’, an increasingly high-tech and aspirational enterprise, dedicated to extending the full panoply of human capacities indefinitely. On this view, scientific training trumps practitioner experience, radically invasive and reconstructive procedures become the norm, and death on a physician’s watch is taken to be the ultimate failure. Humanity 2.0 takes this way of thinking to the next level, which involves the abolition of medicine itself. But what exactly would that mean – and what would replace it?

Continue reading “The Abolition of Medicine as a Goal for Humanity 2.0” »

By Richard Van Noorden and Nature magazine — Scientific American

Scientists who work on genomics and are funded by the US National Institutes of Health (NIH) must post their data online so that others can build on the information, the agency has said in an update to its guidelines.

The change, which expands the remit of an earlier data-sharing policy, is not expected to drastically alter research practices — many genomics researchers are accustomed to sharing their data. But the latest policy, released on 27 August, gives clearer instructions for gaining the informed consent of study participants. The NIH will now require researchers to tell study participants that their data may be broadly shared for future research.

Read more